APO Research
Talk to an analyst

APO RESEARCH · REPORT

Unfractionated Heparin Sodium API

Compare research editions
View pricing & licenses

Selected research

Industry Research

Unfractionated Heparin Sodium API Industry Research Report 2026

19 December 2025138 pages

Choose your research edition.

Industry ResearchUnfractionated Heparin Sodium API Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Unfractionated Heparin Sodium API Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Unfractionated Heparin Sodium API Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Unfractionated Heparin Sodium API Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Unfractionated Heparin Sodium API Market Analysis and Forecast 2026-2032211 pages · $4,950 USD

Market perspective

The global Unfractionated Heparin Sodium API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Unfractionated Heparin Sodium API is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Unfractionated Heparin Sodium API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Unfractionated Heparin Sodium API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Unfractionated Heparin Sodium API include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Unfractionated Heparin Sodium API market in revenue (US$ million) and, where applicable, sales volume (B units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/B units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Unfractionated Heparin Sodium API.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Unfractionated Heparin Sodium API Market by Company

Aspen Oss

Bioibérica

Opocrin

Pfizer

Hebei Changshan Biochemical Pharmaceutical

Cisen Pharmaceutical

Yantai Dongcheng Pharmaceutical

Shenzhen Hepalink Pharmaceutical

Hubei Enoray Biopharmaceutical

Nanjing King-friend Biochemical Pharmaceutical

Qingdao Jiulong Biopharmaceutical

Changzhou Qianhong Biopharma

Dongying Tiandong Pharmaceutical

Nanjing Xinbai Pharmaceutical

Yino Pharma

Unfractionated Heparin Sodium API Segment by Type

USP Grade

EP Grade

Other

Unfractionated Heparin Sodium API Segment by Application

Cardiovascular Disease

Dialysis Anticoagulation

Postoperative Thrombosis Prevention

Other

Unfractionated Heparin Sodium API Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Unfractionated Heparin Sodium API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Unfractionated Heparin Sodium API and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Unfractionated Heparin Sodium API.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Unfractionated Heparin Sodium API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Unfractionated Heparin Sodium API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Unfractionated Heparin Sodium API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Unfractionated Heparin Sodium API Production by Manufacturers (B units) & (2021-2026) Table 6. Global Unfractionated Heparin Sodium API Production Market Share by Manufacturers Table 7. Global Unfractionated Heparin Sodium API Production Value by Manufacturers (US$ Million) & (2021-2026) Table 8. Global Unfractionated Heparin Sodium API Production Value Market Share by Manufacturers (2021-2026) Table 9. Global Unfractionated Heparin Sodium API Average Price (USD/B unit) of Manufacturers (2021-2026) Table 10. Global Unfractionated Heparin Sodium API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Unfractionated Heparin Sodium API Key Manufacturers, Manufacturing Sites & Headquarters Table 12. Global Unfractionated Heparin Sodium API Manufacturers, Product Type & Application Table 13. Global Unfractionated Heparin Sodium API Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Unfractionated Heparin Sodium API by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans Table 17. Aspen Oss Company Information Table 18. Aspen Oss Business Overview Table 19. Aspen Oss Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 20. Aspen Oss Unfractionated Heparin Sodium API Product Portfolio Table 21. Aspen Oss Recent Development Table 22. Bioibérica Company Information Table 23. Bioibérica Business Overview Table 24. Bioibérica Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 25. Bioibérica Unfractionated Heparin Sodium API Product Portfolio Table 26. Bioibérica Recent Development Table 27. Opocrin Company Information Table 28. Opocrin Business Overview Table 29. Opocrin Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 30. Opocrin Unfractionated Heparin Sodium API Product Portfolio Table 31. Opocrin Recent Development Table 32. Pfizer Company Information Table 33. Pfizer Business Overview Table 34. Pfizer Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 35. Pfizer Unfractionated Heparin Sodium API Product Portfolio Table 36. Pfizer Recent Development Table 37. Hebei Changshan Biochemical Pharmaceutical Company Information Table 38. Hebei Changshan Biochemical Pharmaceutical Business Overview Table 39. Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 40. Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio Table 41. Hebei Changshan Biochemical Pharmaceutical Recent Development Table 42. Cisen Pharmaceutical Company Information Table 43. Cisen Pharmaceutical Business Overview Table 44. Cisen Pharmaceutical Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 45. Cisen Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio Table 46. Cisen Pharmaceutical Recent Development Table 47. Yantai Dongcheng Pharmaceutical Company Information Table 48. Yantai Dongcheng Pharmaceutical Business Overview Table 49. Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 50. Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio Table 51. Yantai Dongcheng Pharmaceutical Recent Development Table 52. Shenzhen Hepalink Pharmaceutical Company Information Table 53. Shenzhen Hepalink Pharmaceutical Business Overview Table 54. Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 55. Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio Table 56. Shenzhen Hepalink Pharmaceutical Recent Development Table 57. Hubei Enoray Biopharmaceutical Company Information Table 58. Hubei Enoray Biopharmaceutical Business Overview Table 59. Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 60. Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Product Portfolio Table 61. Hubei Enoray Biopharmaceutical Recent Development Table 62. Nanjing King-friend Biochemical Pharmaceutical Company Information Table 63. Nanjing King-friend Biochemical Pharmaceutical Business Overview Table 64. Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 65. Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio Table 66. Nanjing King-friend Biochemical Pharmaceutical Recent Development Table 67. Qingdao Jiulong Biopharmaceutical Company Information Table 68. Qingdao Jiulong Biopharmaceutical Business Overview Table 69. Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 70. Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Product Portfolio Table 71. Qingdao Jiulong Biopharmaceutical Recent Development Table 72. Changzhou Qianhong Biopharma Company Information Table 73. Changzhou Qianhong Biopharma Business Overview Table 74. Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 75. Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Product Portfolio Table 76. Changzhou Qianhong Biopharma Recent Development Table 77. Dongying Tiandong Pharmaceutical Company Information Table 78. Dongying Tiandong Pharmaceutical Business Overview Table 79. Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 80. Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio Table 81. Dongying Tiandong Pharmaceutical Recent Development Table 82. Nanjing Xinbai Pharmaceutical Company Information Table 83. Nanjing Xinbai Pharmaceutical Business Overview Table 84. Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 85. Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Product Portfolio Table 86. Nanjing Xinbai Pharmaceutical Recent Development Table 87. Yino Pharma Company Information Table 88. Yino Pharma Business Overview Table 89. Yino Pharma Unfractionated Heparin Sodium API Production (B units), Value (US$ Million), Price (USD/B unit) and Gross Margin (2021-2026) Table 90. Yino Pharma Unfractionated Heparin Sodium API Product Portfolio Table 91. Yino Pharma Recent Development Table 92. Global Unfractionated Heparin Sodium API Production Comparison by Region: 2021 VS 2025 VS 2032 (B units) Table 93. Global Unfractionated Heparin Sodium API Production by Region (2021-2026) & (B units) Table 94. Global Unfractionated Heparin Sodium API Production Market Share by Region (2021-2026) Table 95. Global Unfractionated Heparin Sodium API Production Forecast by Region (2027-2032) & (B units) Table 96. Global Unfractionated Heparin Sodium API Production Market Share Forecast by Region (2027-2032) Table 97. Global Unfractionated Heparin Sodium API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 98. Global Unfractionated Heparin Sodium API Production Value by Region (2021-2026) & (US$ Million) Table 99. Global Unfractionated Heparin Sodium API Production Value Market Share by Region (2021-2026) Table 100. Global Unfractionated Heparin Sodium API Production Value Forecast by Region (2027-2032) & (US$ Million) Table 101. Global Unfractionated Heparin Sodium API Market Average Price (USD/B unit) by Region (2021-2026) Table 102. Global Unfractionated Heparin Sodium API Market Average Price (USD/B unit) by Region (2027-2032) Table 103. Global Unfractionated Heparin Sodium API Consumption Comparison by Region: 2021 VS 2025 VS 2032 (B units) Table 104. Global Unfractionated Heparin Sodium API Consumption by Region (2021-2026) & (B units) Table 105. Global Unfractionated Heparin Sodium API Consumption Market Share by Region (2021-2026) Table 106. Global Unfractionated Heparin Sodium API Forecasted Consumption by Region (2027-2032) & (B units) Table 107. Global Unfractionated Heparin Sodium API Forecasted Consumption Market Share by Region (2027-2032) Table 108. North America Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (B units) Table 109. North America Unfractionated Heparin Sodium API Consumption by Country (2021-2026) & (B units) Table 110. North America Unfractionated Heparin Sodium API Consumption by Country (2027-2032) & (B units) Table 111. Europe Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (B units) Table 112. Europe Unfractionated Heparin Sodium API Consumption by Country (2021-2026) & (B units) Table 113. Europe Unfractionated Heparin Sodium API Consumption by Country (2027-2032) & (B units) Table 114. Asia Pacific Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (B units) Table 115. Asia Pacific Unfractionated Heparin Sodium API Consumption by Country (2021-2026) & (B units) Table 116. Asia Pacific Unfractionated Heparin Sodium API Consumption by Country (2027-2032) & (B units) Table 117. South America, Middle East & Africa Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (B units) Table 118. South America, Middle East & Africa Unfractionated Heparin Sodium API Consumption by Country (2021-2026) & (B units) Table 119. South America, Middle East & Africa Unfractionated Heparin Sodium API Consumption by Country (2027-2032) & (B units) Table 120. Global Unfractionated Heparin Sodium API Production by Type (2021-2026) & (B units) Table 121. Global Unfractionated Heparin Sodium API Production by Type (2027-2032) & (B units) Table 122. Global Unfractionated Heparin Sodium API Production Market Share by Type (2021-2026) Table 123. Global Unfractionated Heparin Sodium API Production Market Share by Type (2027-2032) Table 124. Global Unfractionated Heparin Sodium API Production Value by Type (2021-2026) & (US$ Million) Table 125. Global Unfractionated Heparin Sodium API Production Value by Type (2027-2032) & (US$ Million) Table 126. Global Unfractionated Heparin Sodium API Production Value Market Share by Type (2021-2026) Table 127. Global Unfractionated Heparin Sodium API Production Value Market Share by Type (2027-2032) Table 128. Global Unfractionated Heparin Sodium API Price by Type (2021-2026) & (USD/B unit) Table 129. Global Unfractionated Heparin Sodium API Price by Type (2027-2032) & (USD/B unit) Table 130. Global Unfractionated Heparin Sodium API Production by Application (2021-2026) & (B units) Table 131. Global Unfractionated Heparin Sodium API Production by Application (2027-2032) & (B units) Table 132. Global Unfractionated Heparin Sodium API Production Market Share by Application (2021-2026) Table 133. Global Unfractionated Heparin Sodium API Production Market Share by Application (2027-2032) Table 134. Global Unfractionated Heparin Sodium API Production Value by Application (2021-2026) & (US$ Million) Table 135. Global Unfractionated Heparin Sodium API Production Value by Application (2027-2032) & (US$ Million) Table 136. Global Unfractionated Heparin Sodium API Production Value Market Share by Application (2021-2026) Table 137. Global Unfractionated Heparin Sodium API Production Value Market Share by Application (2027-2032) Table 138. Global Unfractionated Heparin Sodium API Price by Application (2021-2026) & (USD/B unit) Table 139. Global Unfractionated Heparin Sodium API Price by Application (2027-2032) & (USD/B unit) Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Unfractionated Heparin Sodium API Distributors List Table 143. Unfractionated Heparin Sodium API Customers List Table 144. Unfractionated Heparin Sodium API Industry Trends Table 145. Unfractionated Heparin Sodium API Industry Drivers Table 146. Unfractionated Heparin Sodium API Industry Restraints Table 147. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Unfractionated Heparin Sodium API Product Image Figure 5. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. USP Grade Product Image Figure 7. EP Grade Product Image Figure 8. Other Product Image Figure 9. Cardiovascular Disease Product Image Figure 10. Dialysis Anticoagulation Product Image Figure 11. Postoperative Thrombosis Prevention Product Image Figure 12. Other Product Image Figure 13. Global Unfractionated Heparin Sodium API Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Unfractionated Heparin Sodium API Production Value (2021-2032) & (US$ Million) Figure 15. Global Unfractionated Heparin Sodium API Production Capacity (2021-2032) & (B units) Figure 16. Global Unfractionated Heparin Sodium API Production (2021-2032) & (B units) Figure 17. Global Unfractionated Heparin Sodium API Average Price (USD/B unit) & (2021-2032) Figure 18. Global Unfractionated Heparin Sodium API Key Manufacturers, Manufacturing Sites & Headquarters Figure 19. Global Top 5 and 10 Unfractionated Heparin Sodium API Players Market Share by Production Value in 2025 Figure 20. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Unfractionated Heparin Sodium API Production Comparison by Region: 2021 VS 2025 VS 2032 (B units) Figure 22. Global Unfractionated Heparin Sodium API Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 23. Global Unfractionated Heparin Sodium API Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Unfractionated Heparin Sodium API Production Value Market Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Unfractionated Heparin Sodium API Production Value (US$ Million) Growth Rate (2021-2032) Figure 26. Europe Unfractionated Heparin Sodium API Production Value (US$ Million) Growth Rate (2021-2032) Figure 27. China Unfractionated Heparin Sodium API Production Value (US$ Million) Growth Rate (2021-2032) Figure 28. Japan Unfractionated Heparin Sodium API Production Value (US$ Million) Growth Rate (2021-2032) Figure 29. Global Unfractionated Heparin Sodium API Consumption Comparison by Region: 2021 VS 2025 VS 2032 (B units) Figure 30. Global Unfractionated Heparin Sodium API Consumption Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 32. North America Unfractionated Heparin Sodium API Consumption Market Share by Country (2021-2032) Figure 33. United States Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 34. United States Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 35. Canada Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 36. Mexico Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 37. Europe Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 38. Europe Unfractionated Heparin Sodium API Consumption Market Share by Country (2021-2032) Figure 39. Germany Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 40. France Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 41. U.K. Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 42. Italy Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 43. Russia Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 44. Spain Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 45. Netherlands Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 46. Switzerland Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 47. Sweden Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 48. Poland Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 49. Asia Pacific Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 50. Asia Pacific Unfractionated Heparin Sodium API Consumption Market Share by Country (2021-2032) Figure 51. China Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 52. Japan Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 53. South Korea Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 54. India Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 55. Australia Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 56. Taiwan Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 57. Southeast Asia Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 58. South America, Middle East & Africa Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 59. South America, Middle East & Africa Unfractionated Heparin Sodium API Consumption Market Share by Country (2021-2032) Figure 60. Brazil Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 61. Argentina Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 62. Chile Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 63. Turkey Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 64. GCC Countries Unfractionated Heparin Sodium API Consumption and Growth Rate (2021-2032) & (B units) Figure 65. Global Unfractionated Heparin Sodium API Production Market Share by Type (2021-2032) Figure 66. Global Unfractionated Heparin Sodium API Production Value Market Share by Type (2021-2032) Figure 67. Global Unfractionated Heparin Sodium API Price (USD/B unit) by Type (2021-2032) Figure 68. Global Unfractionated Heparin Sodium API Production Market Share by Application (2021-2032) Figure 69. Global Unfractionated Heparin Sodium API Production Value Market Share by Application (2021-2032) Figure 70. Global Unfractionated Heparin Sodium API Price (USD/B unit) by Application (2021-2032) Figure 71. Unfractionated Heparin Sodium API Value Chain Figure 72. Unfractionated Heparin Sodium API Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Unfractionated Heparin Sodium API Industry Opportunities and Challenges

Scope & coverage.

Types
  • USP Grade
  • EP Grade
  • Other
Applications
  • Cardiovascular Disease
  • Dialysis Anticoagulation
  • Postoperative Thrombosis Prevention
  • Other
Companies covered
  • Aspen Oss
  • Bioibérica
  • Opocrin
  • Pfizer
  • Hebei Changshan Biochemical Pharmaceutical
  • Cisen Pharmaceutical
  • Yantai Dongcheng Pharmaceutical
  • Shenzhen Hepalink Pharmaceutical
  • Hubei Enoray Biopharmaceutical
  • Nanjing King-friend Biochemical Pharmaceutical
  • Qingdao Jiulong Biopharmaceutical
  • Changzhou Qianhong Biopharma
  • Dongying Tiandong Pharmaceutical
  • Nanjing Xinbai Pharmaceutical
  • Yino Pharma

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Unfractionated Heparin Sodium API by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  4. 2.2.2 USP Grade
  5. 2.2.3 EP Grade
  6. 2.2.4 Other
  7. 2.3 Unfractionated Heparin Sodium API by Application
  8. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
  9. 2.3.2 Cardiovascular Disease
  10. 2.3.3 Dialysis Anticoagulation
  11. 2.3.4 Postoperative Thrombosis Prevention
  12. 2.3.5 Other
  13. 2.4 Global Market Growth Prospects
  14. 2.4.1 Global Unfractionated Heparin Sodium API Production Value Estimates and Forecasts (2021-2032)
  15. 2.4.2 Global Unfractionated Heparin Sodium API Production Capacity Estimates and Forecasts (2021-2032)
  16. 2.4.3 Global Unfractionated Heparin Sodium API Production Estimates and Forecasts (2021-2032)
  17. 2.4.4 Global Unfractionated Heparin Sodium API Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Unfractionated Heparin Sodium API Production by Manufacturers (2021-2026)
  2. 3.2 Global Unfractionated Heparin Sodium API Production Value by Manufacturers (2021-2026)
  3. 3.3 Global Unfractionated Heparin Sodium API Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Unfractionated Heparin Sodium API Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Unfractionated Heparin Sodium API Key Manufacturers, Manufacturing Sites & Headquarters
  6. 3.6 Global Unfractionated Heparin Sodium API Manufacturers, Product Type & Application
  7. 3.7 Global Unfractionated Heparin Sodium API Manufacturers Established Date
  8. 3.8 Global Unfractionated Heparin Sodium API Market CR5 and HHI
  9. 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Aspen Oss
  2. 4.1.1 Aspen Oss Unfractionated Heparin Sodium API Company Information
  3. 4.1.2 Aspen Oss Unfractionated Heparin Sodium API Business Overview
  4. 4.1.3 Aspen Oss Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  5. 4.1.4 Aspen Oss Product Portfolio
  6. 4.1.5 Aspen Oss Recent Developments
  7. 4.2 Bioibérica
  8. 4.2.1 Bioibérica Unfractionated Heparin Sodium API Company Information
  9. 4.2.2 Bioibérica Unfractionated Heparin Sodium API Business Overview
  10. 4.2.3 Bioibérica Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  11. 4.2.4 Bioibérica Product Portfolio
  12. 4.2.5 Bioibérica Recent Developments
  13. 4.3 Opocrin
  14. 4.3.1 Opocrin Unfractionated Heparin Sodium API Company Information
  15. 4.3.2 Opocrin Unfractionated Heparin Sodium API Business Overview
  16. 4.3.3 Opocrin Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  17. 4.3.4 Opocrin Product Portfolio
  18. 4.3.5 Opocrin Recent Developments
  19. 4.4 Pfizer
  20. 4.4.1 Pfizer Unfractionated Heparin Sodium API Company Information
  21. 4.4.2 Pfizer Unfractionated Heparin Sodium API Business Overview
  22. 4.4.3 Pfizer Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  23. 4.4.4 Pfizer Product Portfolio
  24. 4.4.5 Pfizer Recent Developments
  25. 4.5 Hebei Changshan Biochemical Pharmaceutical
  26. 4.5.1 Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Company Information
  27. 4.5.2 Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Business Overview
  28. 4.5.3 Hebei Changshan Biochemical Pharmaceutical Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  29. 4.5.4 Hebei Changshan Biochemical Pharmaceutical Product Portfolio
  30. 4.5.5 Hebei Changshan Biochemical Pharmaceutical Recent Developments
  31. 4.6 Cisen Pharmaceutical
  32. 4.6.1 Cisen Pharmaceutical Unfractionated Heparin Sodium API Company Information
  33. 4.6.2 Cisen Pharmaceutical Unfractionated Heparin Sodium API Business Overview
  34. 4.6.3 Cisen Pharmaceutical Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  35. 4.6.4 Cisen Pharmaceutical Product Portfolio
  36. 4.6.5 Cisen Pharmaceutical Recent Developments
  37. 4.7 Yantai Dongcheng Pharmaceutical
  38. 4.7.1 Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Company Information
  39. 4.7.2 Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Business Overview
  40. 4.7.3 Yantai Dongcheng Pharmaceutical Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  41. 4.7.4 Yantai Dongcheng Pharmaceutical Product Portfolio
  42. 4.7.5 Yantai Dongcheng Pharmaceutical Recent Developments
  43. 4.8 Shenzhen Hepalink Pharmaceutical
  44. 4.8.1 Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Company Information
  45. 4.8.2 Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Business Overview
  46. 4.8.3 Shenzhen Hepalink Pharmaceutical Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  47. 4.8.4 Shenzhen Hepalink Pharmaceutical Product Portfolio
  48. 4.8.5 Shenzhen Hepalink Pharmaceutical Recent Developments
  49. 4.9 Hubei Enoray Biopharmaceutical
  50. 4.9.1 Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Company Information
  51. 4.9.2 Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Business Overview
  52. 4.9.3 Hubei Enoray Biopharmaceutical Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  53. 4.9.4 Hubei Enoray Biopharmaceutical Product Portfolio
  54. 4.9.5 Hubei Enoray Biopharmaceutical Recent Developments
  55. 4.10 Nanjing King-friend Biochemical Pharmaceutical
  56. 4.10.1 Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Company Information
  57. 4.10.2 Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Business Overview
  58. 4.10.3 Nanjing King-friend Biochemical Pharmaceutical Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  59. 4.10.4 Nanjing King-friend Biochemical Pharmaceutical Product Portfolio
  60. 4.10.5 Nanjing King-friend Biochemical Pharmaceutical Recent Developments
  61. 4.11 Qingdao Jiulong Biopharmaceutical
  62. 4.11.1 Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Company Information
  63. 4.11.2 Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Business Overview
  64. 4.11.3 Qingdao Jiulong Biopharmaceutical Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  65. 4.11.4 Qingdao Jiulong Biopharmaceutical Product Portfolio
  66. 4.11.5 Qingdao Jiulong Biopharmaceutical Recent Developments
  67. 4.12 Changzhou Qianhong Biopharma
  68. 4.12.1 Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Company Information
  69. 4.12.2 Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Business Overview
  70. 4.12.3 Changzhou Qianhong Biopharma Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  71. 4.12.4 Changzhou Qianhong Biopharma Product Portfolio
  72. 4.12.5 Changzhou Qianhong Biopharma Recent Developments
  73. 4.13 Dongying Tiandong Pharmaceutical
  74. 4.13.1 Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Company Information
  75. 4.13.2 Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Business Overview
  76. 4.13.3 Dongying Tiandong Pharmaceutical Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  77. 4.13.4 Dongying Tiandong Pharmaceutical Product Portfolio
  78. 4.13.5 Dongying Tiandong Pharmaceutical Recent Developments
  79. 4.14 Nanjing Xinbai Pharmaceutical
  80. 4.14.1 Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Company Information
  81. 4.14.2 Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Business Overview
  82. 4.14.3 Nanjing Xinbai Pharmaceutical Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  83. 4.14.4 Nanjing Xinbai Pharmaceutical Product Portfolio
  84. 4.14.5 Nanjing Xinbai Pharmaceutical Recent Developments
  85. 4.15 Yino Pharma
  86. 4.15.1 Yino Pharma Unfractionated Heparin Sodium API Company Information
  87. 4.15.2 Yino Pharma Unfractionated Heparin Sodium API Business Overview
  88. 4.15.3 Yino Pharma Unfractionated Heparin Sodium API Production Capacity, Value and Gross Margin (2021-2026)
  89. 4.15.4 Yino Pharma Product Portfolio
  90. 4.15.5 Yino Pharma Recent Developments
5 Global Unfractionated Heparin Sodium API Production by Region
  1. 5.1 Global Unfractionated Heparin Sodium API Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Unfractionated Heparin Sodium API Production by Region: 2021-2032
  3. 5.2.1 Global Unfractionated Heparin Sodium API Production by Region: 2021-2026
  4. 5.2.2 Global Unfractionated Heparin Sodium API Production Forecast by Region (2027-2032)
  5. 5.3 Global Unfractionated Heparin Sodium API Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  6. 5.4 Global Unfractionated Heparin Sodium API Production Value by Region: 2021-2032
  7. 5.4.1 Global Unfractionated Heparin Sodium API Production Value by Region: 2021-2026
  8. 5.4.2 Global Unfractionated Heparin Sodium API Production Value Forecast by Region (2027-2032)
  9. 5.5 Global Unfractionated Heparin Sodium API Market Price Analysis by Region (2021-2026)
  10. 5.6 Global Unfractionated Heparin Sodium API Production and Value, YOY Growth
  11. 5.6.1 North America Unfractionated Heparin Sodium API Production Value Estimates and Forecasts (2021-2032)
  12. 5.6.2 Europe Unfractionated Heparin Sodium API Production Value Estimates and Forecasts (2021-2032)
  13. 5.6.3 China Unfractionated Heparin Sodium API Production Value Estimates and Forecasts (2021-2032)
  14. 5.6.4 Japan Unfractionated Heparin Sodium API Production Value Estimates and Forecasts (2021-2032)
6 Global Unfractionated Heparin Sodium API Consumption by Region
  1. 6.1 Global Unfractionated Heparin Sodium API Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Unfractionated Heparin Sodium API Consumption by Region (2021-2032)
  3. 6.2.1 Global Unfractionated Heparin Sodium API Consumption by Region: 2021-2026
  4. 6.2.2 Global Unfractionated Heparin Sodium API Forecasted Consumption by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Unfractionated Heparin Sodium API Consumption by Country (2021-2032)
  8. 6.3.3 United States
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Unfractionated Heparin Sodium API Consumption by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Russia
  19. 6.4.8 Spain
  20. 6.4.9 Netherlands
  21. 6.4.10 Switzerland
  22. 6.4.11 Sweden
  23. 6.4.12 Poland
  24. 6.5 Asia Pacific
  25. 6.5.1 Asia Pacific Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  26. 6.5.2 Asia Pacific Unfractionated Heparin Sodium API Consumption by Country (2021-2032)
  27. 6.5.3 China
  28. 6.5.4 Japan
  29. 6.5.5 South Korea
  30. 6.5.6 India
  31. 6.5.7 Australia
  32. 6.5.8 Taiwan
  33. 6.5.9 Southeast Asia
  34. 6.6 South America, Middle East & Africa
  35. 6.6.1 South America, Middle East & Africa Unfractionated Heparin Sodium API Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  36. 6.6.2 South America, Middle East & Africa Unfractionated Heparin Sodium API Consumption by Country (2021-2032)
  37. 6.6.3 Brazil
  38. 6.6.4 Argentina
  39. 6.6.5 Chile
  40. 6.6.6 Turkey
  41. 6.6.7 GCC Countries
7 Segment by Type
  1. 7.1 Global Unfractionated Heparin Sodium API Production by Type (2021-2032)
  2. 7.1.1 Global Unfractionated Heparin Sodium API Production by Type (2021-2032) & (B units)
  3. 7.1.2 Global Unfractionated Heparin Sodium API Production Market Share by Type (2021-2032)
  4. 7.2 Global Unfractionated Heparin Sodium API Production Value by Type (2021-2032)
  5. 7.2.1 Global Unfractionated Heparin Sodium API Production Value by Type (2021-2032) & (US$ Million)
  6. 7.2.2 Global Unfractionated Heparin Sodium API Production Value Market Share by Type (2021-2032)
  7. 7.3 Global Unfractionated Heparin Sodium API Price by Type (2021-2032)
8 Segment by Application
  1. 8.1 Global Unfractionated Heparin Sodium API Production by Application (2021-2032)
  2. 8.1.1 Global Unfractionated Heparin Sodium API Production by Application (2021-2032) & (B units)
  3. 8.1.2 Global Unfractionated Heparin Sodium API Production Market Share by Application (2021-2032)
  4. 8.2 Global Unfractionated Heparin Sodium API Production Value by Application (2021-2032)
  5. 8.2.1 Global Unfractionated Heparin Sodium API Production Value by Application (2021-2032) & (US$ Million)
  6. 8.2.2 Global Unfractionated Heparin Sodium API Production Value Market Share by Application (2021-2032)
  7. 8.3 Global Unfractionated Heparin Sodium API Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
  1. 9.1 Unfractionated Heparin Sodium API Value Chain Analysis
  2. 9.1.1 Unfractionated Heparin Sodium API Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Unfractionated Heparin Sodium API Production Mode & Process
  5. 9.2 Unfractionated Heparin Sodium API Sales Channels Analysis
  6. 9.2.1 Direct Comparison with Distribution Share
  7. 9.2.2 Unfractionated Heparin Sodium API Distributors
  8. 9.2.3 Unfractionated Heparin Sodium API Customers
10 Global Unfractionated Heparin Sodium API Analyzing Market Dynamics
  1. 10.1 Unfractionated Heparin Sodium API Industry Trends
  2. 10.2 Unfractionated Heparin Sodium API Industry Drivers
  3. 10.3 Unfractionated Heparin Sodium API Industry Opportunities and Challenges
  4. 10.4 Unfractionated Heparin Sodium API Industry Restraints
11 Report Conclusion
    12 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst